Surmodics to Attend Piper Jaffray Healthcare Conference
November 22 2016 - 8:05AM
Business Wire
Webcast is Live on Tuesday, November 29, at
11:30 a.m. (ET)
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, today announced that Gary Maharaj, president and chief
executive officer, and Andy LaFrence, vice president of finance and
information systems and chief financial officer, will attend the
28th Annual Piper Jaffray Healthcare Conference in New York
City on Tuesday, November 29, 2016. The fireside chat will begin at
11:30 a.m. ET (10:30 a.m. CT), and the live audio webcast can be
accessed by going to the investor relations portion of the
Company’s website at www.surmodics.com and clicking on the webcast
icon. The webcast will be archived on the Company’s website for
90 days following the meeting.
About Surmodics, Inc.
Surmodics is the global leader in surface modification
technologies for intravascular medical devices and a leading
provider of chemical components for in vitro diagnostic (IVD) tests
and microarrays. Following two recent acquisitions of Creagh
Medical and NorMedix, the Company is executing a key growth
strategy for its medical device business by expanding to offer
total intravascular product solutions to its medical device
customers. The combination of proprietary surface technologies,
along with enhanced device design, development and manufacturing
capabilities, enables Surmodics to significantly increase the value
it offers with highly differentiated intravascular solutions
designed and engineered to the most demanding requirements. With
this focus on offering total solutions, Surmodics’ mission remains
to improve the detection and treatment of disease. Surmodics is
headquartered in Eden Prairie, Minnesota. For more information
about the company, visit www.surmodics.com. The content of
Surmodics’ website is not part of this press release or part of any
filings that the company makes with the SEC.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161122005278/en/
Surmodics, Inc.Andy LaFrence,
952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2023 to Apr 2024